相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biological treatment for psoriasis and the risk of herpes zoster: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Guy Shalom et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2019)
Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1)
Desiree van der Heijde et al.
JOURNAL OF RHEUMATOLOGY (2018)
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study
Juul M. P. A. van den Reek et al.
ACTA DERMATO-VENEREOLOGICA (2018)
Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
Zenas Z. N. Yiu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Risk of Serious Infection, Opportunistic Infection, and Herpes Zoster among Patients with Psoriasis in the United Kingdom
Junko Takeshita et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
Atul Deodhar et al.
LANCET (2018)
Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial
Alvin F. Wells et al.
RHEUMATOLOGY (2018)
Real-world use of apremilast for patients with psoriasis in Japan
Megumi Kishimoto et al.
JOURNAL OF DERMATOLOGY (2018)
Treating Moderate-to-Severe Plaque Psoriasis With Guselkumab: A Review of Phase II and Phase III Trials
Seth T. Howell et al.
ANNALS OF PHARMACOTHERAPY (2018)
Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry
Paula Davila-Seijo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Serious infections among a large cohort of subjects with systemically treated psoriasis
Allison S. Dobry et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Herpes zoster in psoriasis patients treated with tofacitinib
Kevin L. Winthrop et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparatore-controlled VOYAGE 1 trial
Andrew Blauvelt et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti-tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries
Ignacio Garcia-Doval et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study
Rishi J. Desai et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study
Rishi J. Desai et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Apremilast: A Review in Psoriasis and Psoriatic Arthritis
Gillian M. Keating
DRUGS (2017)
Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis
Jeffrey R. Curtis et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
The Incidence and Predictors of Infection in Psoriasis and Psoriatic Arthritis: Results from Longitudinal Observational Cohorts
Amir Haddad et al.
JOURNAL OF RHEUMATOLOGY (2016)
Serious infections in hospitalized patients with psoriasis in the United States
Derek Y. Hsu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies
Sarah Elyoussfi et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials
Benjamin Farahnik et al.
DERMATOLOGY AND THERAPY (2016)
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis
Kenneth B. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Systemic Therapy for Psoriasis and the Risk of Herpes Zoster A 500000 Person-year Study
Guy Shalom et al.
JAMA DERMATOLOGY (2015)
Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Robert E. Kalb et al.
JAMA DERMATOLOGY (2015)
A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE)
K. . Papp et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry
C. Medina et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study
John W. Baddley et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
Richard G. Langley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Psoriasis and the Risk of Pneumonia: A Population-Based Study
Li-Ting Kao et al.
PLOS ONE (2014)
Psoriasis and Psoriatic Arthritis A Public Health Agenda
Charles G. Helmick et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2013)
The association between psoriasis and dyslipidaemia: a systematic review
C. Ma et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries
I. Garcia-Doval et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
The association between psoriasis and hypertension: a systematic reviewandmeta-analysis of observational studies
April W. Armstrong et al.
JOURNAL OF HYPERTENSION (2013)
Cardiovascular Comorbidities of Psoriasis and Psoriatic Arthritis: A Report from the GRAPPA 2012 Annual Meeting
April W. Armstrong et al.
JOURNAL OF RHEUMATOLOGY (2013)
Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Observational Studies
Ehrin J. Armstrong et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies
A. W. Armstrong et al.
NUTRITION & DIABETES (2012)
Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
A. Strangfeld et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases
Carlos G. Grijalva et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Increased risk of infectious disease requiring hospitalization among patients with psoriasis: A population-based cohort
Marlies Wakkee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy
K. L. Winthrop et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK
K. Abuabara et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004
Shanu Kohli Kurd et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Epidemiology of psoriatic arthritis in the population of the United States
JM Gelfand et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
分享论文
